Opioid Use Disorder Market , By Drug Type (Buprenorphine, Methadone, Naltrexone, and Others), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
Opioid Use Disorder Market , By Drug Type (Buprenorphine, Methadone, Naltrexone, and Others), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
Opioids are naturally or synthetically made in laboratories to interact with opioid receptors on the nerve cells in the body and brain, and helps in reducing pain. These are class of drugs that include prescription pain relievers, synthetic opioids, and heroin. Prescription opioids are used to treat acute pain such as recovering from injury or post-surgery, chronic pain, active-phase cancer treatment, palliative care, and end-of-life care. Many people rely on prescription opioids to manage their conditions under the care of a physician. Opioid use disorder is a chronic lifelong disorder, with serious potential consequences including disability, relapses, and death.
Methadone is a full opioid agonist that works by binding to the mu-opioid receptors in the brain to relieve cramps and withdrawal symptoms. It comes in a liquid form that must be administered daily under medical supervision. This makes it challenging for some patients but also reduces abuse and diversion risks. Buprenorphine is a partial opioid agonist that provides pain relief without the typical euphoria. Naltrexone is an opioid antagonist that blocks the effects of other opioids. The oral form must be taken daily while the injectable extended-release version lasts for monthly doses.
Market Dynamics
Global opioid use disorder market growth is driven by increasing product launches by key market players to expand their product portfolio. For instance, in December 2021, Sandoz, a global leader in generic and biosimilar medicines, announced the U.S. launch of its authorized generic of Narcan (naloxone hydrochloride) Nasal Spray 4mg that is used to reverse opioid overdose. It is available to people in the U.S. via retail pharmacies and institutions including hospitals.
Key features of the study:
- This report provides an in-depth analysis of the global opioid use disorder market and provides market size (US$ Bn) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global opioid use disorder market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
- The key companies covered as a part of this study include Indivior PLC, Alkermes, Orexo AB, Titan Pharmaceuticals, Inc, Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, BioDelivery Sciences International Inc., Viatris Inc., Hikma Pharmaceuticals PLC, Camurus AB, Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC., Purdue Pharma LP, Alvogen, Faran Shimi Pharmaceutical, Novartis AG, Emplicure AB, and MODASA Pharmaceuticals Pvt. Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global opioid use disorder market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing global opioid use disorder market
- By Drug Type:
- Buprenorphine
- Methadone
- Naltrexone
- Others
- By Route of Administration:
- Oral
- Parenteral
- By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles
- Indivior PLC
- Alkermes
- Orexo AB
- Titan Pharmaceuticals, Inc.
- Teva Pharmaceutical Industries Ltd.
- Mallinckrodt Pharmaceuticals
- BioDelivery Sciences International Inc.
- Viatris Inc.
- Hikma Pharmaceuticals PLC
- Camurus AB
- Sun Pharmaceutical Industries Ltd.
- Amneal Pharmaceuticals LLC.
- Purdue Pharma LP
- Alvogen
- Faran Shimi Pharmaceutical
- Novartis AG
- Emplicure AB
- MODASA Pharmaceuticals Pvt. Ltd.
- 1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Recent Test Launches
- Product Launches/Approvals
- Mergers, Acquisitions, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- PORTER’s Analysis
- 4. Global Opioid Use Disorder Market, – COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
- 5. Global Opioid Use Disorder Market, By Drug Type, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019–2030
- Segment Trends
- Buprenorphine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Methadone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Naltrexone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- 6. Global Opioid Use Disorder Market, By Route of Administration, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019–2030
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- 7. Global Opioid Use Disorder Market, By Distribution Channel, 2018 – 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019–2030
- Segment Trends
- Hospitals Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- 8. Global Opioid Use Disorder Market, By Region, 2018 – 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019–2030
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 –2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 –2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018–2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 –2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 –2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018–2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 –2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 –2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018–2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 –2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 –2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018–2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 –2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 –2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018–2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 –2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 –2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018–2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018–2030, (US$ Bn)
- North Africa
- Central Africa
- South Africa
- 9. Competitive Landscape
- Company Profiles
- Indivior PLC
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Alkermes
- Orexo AB
- Titan Pharmaceuticals, Inc.
- Teva Pharmaceutical Industries Ltd.
- Mallinckrodt Pharmaceuticals
- BioDelivery Sciences International Inc.
- Viatris Inc.
- Hikma Pharmaceuticals PLC
- Camurus AB
- Sun Pharmaceutical Industries Ltd.
- Amneal Pharmaceuticals LLC.
- Purdue Pharma LP
- Alvogen
- Faran Shimi Pharmaceutical
- Novartis AG
- Emplicure AB
- MODASA Pharmaceuticals Pvt. Ltd.
- Analysts’ Views
- 10. Section
- References
- Research Methodology
- About us and Sales Contact
- *Browse 35 market data tables and 31 figures on “Global Opioid Use Disorder Market,” – Global forecast to 2030
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook